Beauty’s 600% surge is backed by digital strength, global growth, and top-tier margins despite valuation risks. Read why ELF ...

Sarepta Therapeutics faces major risks in 2025 with stock collapse, halted therapies, and financial woes. Click here to read ...

In June, the province appointed supervisors to oversee the finances and operations of four school boards, largely sidelining ...